Plowman, Gregory D.
Eli Lilly (United States)
3 papers on CoChatORCID 0000-0002-6465-309X
Most cited papers
- Verified
Identification of a novel contactin‐associated transmembrane receptor with multiple domains implicated in protein–protein interactions
Peles, E., Nativ, M., Lustig, M., Grumet, M., Schilling, J., Martinez, R., Plowman, G. D., & Schlessinger, J. (1997) · The EMBO Journal
Axon Guidance and Neuronal SignalingNeuroscience and Neuropharmacology Research
Cited by 400
- Verified
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., et al. (2018) · Journal for ImmunoTherapy of Cancer
TGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
Cited by 356
- Verified
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Chen, S.-H., Zhang, Y., Van Horn, R. D., Yin, T., Buchanan, S., Yadav, V., Mochalkin, I., Wong, S. S., Yue, Y. G., Huber, L., et al. (2016) · Cancer Discovery
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 171
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free